Activin A: a novel urinary biomarker of renal impairment in multiple myeloma

Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality. However, no useful biomarkers for early detection of renal damage in MM exist. Reports indicate that activin A, a multifunctional cytokine of the TGF-β superfamily, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Iriuchishima, Hirono, Maeshima, Akito, Takahashi, Shunsuke, Ishizaki, Takuma, Yokohama, Akihiko, Tsukamoto, Norifumi, Saitoh, Takayuki, Murakami, Hirokazu, Handa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542761/
https://www.ncbi.nlm.nih.gov/pubmed/31072919
http://dx.doi.org/10.1042/BSR20190206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542761/
https://www.ncbi.nlm.nih.gov/pubmed/31072919
http://dx.doi.org/10.1042/BSR20190206

Ejemplares similares